Live Breaking News & Updates on ஹாரியட் பார்ஹாம்

Stay updated with breaking news from ஹாரியட் பார்ஹாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Singapore Health Sciences Authority (HSA) Approves Interim Authorization of COVID-19 Vaccine Moderna For Use


Press release content from Business Wire. The AP news staff was not involved in its creation.
Singapore Health Sciences Authority (HSA) Approves Interim Authorization of COVID-19 Vaccine Moderna For Use
February 3, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 3, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Singapore Health Sciences Authority (HSA) has approved the interim authorization of its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under the Pandemic Special Access Route (PSAR).
ADVERTISEMENT
“Today’s authorization is another important step in the global fight against COVID-19,” said Stéphane Bancel, Chief Executive Officer of Moderna. “I want to thank the Singapore Ministry of Health and the HSA for their collaboration and for the confidence they have demonstrated in COVID-19 Vaccine Moderna with this decision.” ....

United States , United Kingdom , Lavina Talukdar , Harriet Barham , Colleen Hussey , Us Department Of Defense , National Institute Of Allergy , Singapore Ministry Of Health , Coalition For Epidemic Preparedness Innovations , Israel Ministry Of Health , Singapore Health Sciences Authority , Merck Co Inc , European Union , Moderna Inc , Vaccine Research Center , National Institutes Of Health , World Health Organization , Drug Administration , European Commission , Exchange Commission , Health Sciences Authority , Corporate Communications , Defense Advanced Research Projects Agency , European Medicines Agency , Health Canada , Pandemic Special Access Route ,

United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna


Press release content from Business Wire. The AP news staff was not involved in its creation.
United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna
January 8, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 8, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under Regulation 174. The temporary authorization permits the supply of COVID-19 Vaccine Moderna in Great Britain and is based upon the advice of the UK Commission on Human Medicines. ....

United Kingdom , United States , Great Britain , Lavina Talukdar , Harriet Barham , Us Department Of Defense , United Kingdom Commission On Human Medicines , Coalition For Epidemic Preparedness Innovations , Merck Co Inc , Moderna Inc , European Union On , Vaccine Research Center , Drug Administration , Regulatory Agency , Exchange Commission , Commission On Human Medicine , Defense Advanced Research Projects Agency , Corporate Communications , Commission On Human Medicines , European Medicines Agency , United Kingdom Commission , Chief Executive Officer , Human Medicine , European Union , Epidemic Preparedness Innovations , Fast Track ,